retatrutide clinical trials retatrutide weight loss Results:Trial Data and FDA Status Phase III retatrutide study demonstrates

Measuring GLP-1 Efficacy in the Real World Does real-world evidence show that GLP-1s are as effective as results reported in randomized controlled clinical trials

Figure 1 Statements Author contributions JC, AM, YW, CL, HQ, XM, HY, and LD searched the data, JC, XR, and JZ wrote the main manuscript text

The most common side effects include: Fatigue or tiredness Constipation or difficulty having a bowel movement Diarrhea or loose stools

Timothy Garvey, MD, professor of medicine and director of the University of Alabama at Birminghams Diabetes Research Center

GLP-1 receptor agonists can be valuable tools for managing diabetes and weight in patients with Hashimoto's disease when used appropriately and with proper monitoring

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation